P-glycoprotein Inhibition Increases the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents

The effects of mGlu7 receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains

(2013) Richard M. O’Connor et al.   BEHAVIOURAL PHARMACOLOGY

Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats

(2012) FE O'Brien et al.   BRITISH JOURNAL OF PHARMACOLOGY

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

(2012) A B Singh et al.   Translational Psychiatry

Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings

(2011) Fionn E O'Brien et al.   BRITISH JOURNAL OF PHARMACOLOGY

Failure to Replicate Genetic Associations with Antidepressant Treatment Response in Duloxetine-Treated Patients

(2010) Roy H. Perlis et al.   BIOLOGICAL PSYCHIATRY

Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites

(2010) Nora Unceta et al.   BIOMEDICAL CHROMATOGRAPHY

Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport

(2010) Konstantin Kuteykin-Teplyakov et al.   BRITISH JOURNAL OF PHARMACOLOGY

Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test

(2010) Andréa D.E. Zomkowski et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Blood–brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein

(2010) Louise Karlsson et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

MRP1 Polymorphisms Associated With Citalopram Response in Patients With Major Depression

(2010) Sung Hee Lee et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression

(2010) Jane E. Sarginson et al.   Pharmacogenetics and Genomics

Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

(2008) S. Syvanen et al.   DRUG METABOLISM AND DISPOSITION

Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression

(2008) Manfred Uhr et al.   NEURON

Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: A pilot study

(2008) G NIKISCH et al.   PHARMACOLOGICAL RESEARCH

ABC multidrug transporters: structure, function and role in chemoresistance

(2007) Frances J Sharom   PHARMACOGENOMICS

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder

(2007) Masaki Kato et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY